FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.350
-0.010 (-0.74%)
Sep 25, 2026, 10:21 AM EDT - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $9.39 million as of September 25, 2026. Its market cap has decreased by -62.78% in one year.
Market Cap
9.39M
Enterprise Value
7.34M
1-Year Change
-62.78%
Ranking
Category
Stock Price
$1.35
ChartMarket Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $9.39M, a decrease of -99.01%. That is a compound annual growth rate of -82.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 9.39M | -37.22% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences Holdings | 10.68M |
| Enlivex | 10.59M |
| Theriva Biologics | 10.58M |
| Immuron | 10.42M |
| Azitra | 10.12M |
| Aprea Therapeutics | 9.82M |
| Longeveron | 9.28M |
| Lunai Bioworks | 8.80M |